Believe it or not, you can say good riddance to wrinkles. And even though the lines on our skin are a normal way of aging, these creases don’t leave you with a healthy, clear complexion like you once ...
Revance Shares Jump 17% After FDA Approves Botox Rival
Shares of Revance Therapeutics surged 18% Thursday after the company announced the Food and Drug Administration had approved Daxxify, a facial injection drug that Revance hopes will challenge Botox’s ...
Botox rival’s longer-lasting wrinkle eraser approved by FDA: ‘It’s a big deal’
The Food and Drug Administration has approved a new wrinkle-erasing treatment that could be a serious competitor to Botox, the Wall Street Journal reported Inc’s Daxxify — known also as ...
Spotlight On Vegan Beauty Line M.S Skincare: 5 Must-Haves From $28
Here's what you need to know about vegan beauty line M.S Skincare — and which sustainable skincare products are essentials for your shelf.
F.D.A. OKs Daxxify, an Anti-Wrinkle Drug and Botox Competitor
The treatment lasts for six months in half of its users, company studies showed, representing the first major advance in facial injections in decades.
Best facial essences to hydrate and prepare skin for the next steps
Best facial essences to hydrate and prepare skin for the next steps - These hydrating formulas will counter the drying effects of traditional toners ...
The 37 Best Amazon Beauty Products Under $35 for Fall 2022
Beyond discovering tons of affordable products to upgrade your beauty regimen from the online retailer, you'll also find high-end beauty brand essentials like L'Oreal Revitalift and La Roche-Posay ...
FDA Approves New Botox Rival
Analysts say the drug, from Revance Therapeutics, poses a threat to the market-dominating antiwrinkle treatment because it promises to last longer.
Young, wild and toxed: Why are so many twentysomethings getting Botox and filler?
British dermatologists have spotted an alarming increase in the number of young people using dermal fillers and Botox, while former Disney hunk Joe Jonas is busy promoting Botox’s biggest rival in a ...